loader
Please Wait
Applying Filters...

Parand Darou Pharma Parand Darou Pharma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2023_110___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Cohance Lifesciences

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INTERMEDIATES

    PharmaCompass

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 COHANCE LIFESCIENCES LIMITED Hyderabad IN (1)

    filter

    01 Levodropropizine (1)

    filter

    01 India (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    COHANCE LIFESCIENCES LIMITED Hydera...

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag India
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Levodropropizine

      PDF Supplier PDF
      URL Supplier Web Content
      CEP 2023-110 - Rev 00
      Valid
      Chemical
      2024-05-24
      1535

      CPhI Worldwide, Milan

      Booth #4B1

      envelop Contact Supplier

      Looking for Certificates of Suitability (CEPs) for CEP 2023-110 - Rev 00 of Cohance Lifesciences Limited Hyderabad In

      Looking for Certificates of Suitability (CEPs) for CEP 2023-110 - Rev 00 of Cohance Lifesciences Limited Hyderabad In 1

      20

      Cohance Lifesciences Limited Hyderabad In, based in India, is a pharmaceutical company.

      One of their significant offerings is Levodropropizine, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2023-110 - Rev 00

      This Chemical Type CEP, issued on May 24, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Substance Number 1535 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY